Timothy WeedenVice President- Head of Platform Discovery at Dyne TherapeuticsSpeaker
Profile
Tim Weeden is a leading researcher in the field of oligonucleotide therapeutics, with over 20 years of experience in the discovery and development of small molecules, peptides, and antibody therapeutics across areas of immunology and rare disease. He initiated research efforts focused on the design of the FORCETM platform at Dyne Therapeutics and leads the broader implementation of pipeline and second-generation products. Tim has over 50 issued patents and authored a number of peer-reviewed articles published in leading scientific journals. Tim holds a B.S. degree in Biochemistry from Bridgewater State University.
Agenda Sessions
Clinical Translation of the FORCE™ Platform for Targeted Oligonucleotide Delivery
, 3:00pmView Session